This content is machine translated Study Overview What’s new in the world of cardiology? Scientific research is constantly being pursued, enabling advances to be made time and again in the therapeutic management of cardiological diseases. The most interesting study results around pericarditis, chronic coronary…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 10 min This content is machine translated Cardiology Effects of noise exposure on the cardiovascular system. Traffic noise is a hot topic. The Corona crisis has taught people to appreciate the peace and quiet that occurred in many places over several weeks as a result of… CME-Test
View Post 4 min This content is machine translated Lipid management: LDL cholesterol reduction Add-on to statin therapy recommended in patients at high cardiovascular risk Numerous empirical studies confirm that there is a causal relationship between high LDL cholesterol levels and cardiac events. The current motto with regard to LDL cholesterol reduction is “the lower,…
View Post 12 min This content is machine translated Subsegmental pulmonary emboli In need of therapy or clinically irrelevant? Pulmonary embolism (LE) is grouped together with deep vein thrombosis as venous thromboembolism. Whereas 50 years ago the diagnosis was usually made post-mortem or in the presence of definite clinical… CME-Test
View Post 4 min This content is machine translated Lipid lowering: "The lower, the better" is possible High-risk patients achieve ESC/EAS LDL-C targets in everyday practice. The European observational study HEYMANS with almost 2000 patients has proven that patients with very high cardiovascular risk reach the new target values European Society of Cardiology (ESC) with appropriate…
View Post 3 min This content is machine translated High-risk cardiovascular patients. Strong reduction of LDL-C levels in daily practice achievable by combination therapies Current treatment guidelines recommend low low-density lipoprotein cholesterol (LDL-C) levels for high-risk cardiovascular patients, which are unlikely to be achieved by statin therapy alone [1,2]. The fact that cardiovascular high-risk…
View Post 2 min This content is machine translated Lipid Management Guideline-compliant care up to date A fundamental factor in the field of cardiology is LDL cholesterol. Because without cholesterol, there is no atherosclerosis. Therefore, effective lipid management is paramount for the prevention of cardiovascular events.…
View Post 3 min This content is machine translated SGLT2 inhibitors Cardioprotective effect proven and found to be good – a statement One of the serious long-term consequences of diabetes mellitus is cardiovascular disease. Heart failure, in particular, is common in patients who have had diabetes for a long time. Recent study…
View Post 3 min This content is machine translated Angina pectoris Antianginal therapy shows no long-term benefit for prophylaxis Angina may persist or recur despite successful revascularization with percutaneous coronary intervention. In these cases, antianginal treatment is supplemented. To demonstrate the effectiveness of this approach, a clinical trial was…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
